Asia Pacific: The heart-lung machine market in Asia Pacific is projected to experience rapid growth, especially in countries like China, Japan, and South Korea. Increasing healthcare expenditure, rising adoption of advanced medical technologies, and growing geriatric population are some of the factors driving market growth in this region.
Europe: In Europe, countries like the United Kingdom, Germany, and France are key contributors to the heart-lung machine market. High prevalence of cardiovascular diseases, well-established healthcare facilities, and favorable reimbursement policies are expected to fuel market growth in these countries. Additionally, increasing focus on research and development activities within the healthcare sector is expected to further boost market expansion in Europe.